Zhejiang Conba Pharmaceutical Co., Ltd.
Jiangxi Zhenshiming Pharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, a "hometown of talented men" and a "cultural country" with a prosperous humanistic culture. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. was formerly known as "Fuzhou Pharmaceutical Factory" and was founded in 1968. The company covers an area of 165 mu, with an investment of nearly 100 million yuan. It has been built into a new modern garden-style ophthalmology health enterprise with complete hardware facilities according to the GMP standard, specializing in the research, development, production and sales of eye health consumer products and medicines. It has now developed into a comprehensive company integrating pharmaceutical industry, medical devices, cosmetics, daily necessities production, research and development, sales and pharmaceutical retail. The company has 48 varieties mainly eye drops, 7 products entered the national basic medicine catalog and 25 national medical insurance products. Among them, the four flavors of Zhen Layer Ice Boron Eye Drops (Zhenshi Ming Eye Drops) were included in the National Pharmacopeia and were designated as the teenager's eye drops for myopia designated by the State Education Commission (Document No. 66 of the Education Department [1992]. The company has nearly 100 million yuan. A consumer group with students as the main force. Since 2012, the company has vigorously expanded its health consumer goods business and successfully developed and launched Zhenshiming steam eye masks, eye patches, eye washes and other products.
Zhejiang Conba Pharmaceutical Co., Ltd.
Jiangxi Zhenshiming Pharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, a "hometown of talented men" and a "cultural country" with a prosperous humanistic culture. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. was formerly known as "Fuzhou Pharmaceutical Factory" and was founded in 1968. The company covers an area of 165 mu, with an investment of nearly 100 million yuan. It has been built into a new modern garden-style ophthalmology health enterprise with complete hardware facilities according to the GMP standard, specializing in the research, development, production and sales of eye health consumer products and medicines. It has now developed into a comprehensive company integrating pharmaceutical industry, medical devices, cosmetics, daily necessities production, research and development, sales and pharmaceutical retail. The company has 48 varieties mainly eye drops, 7 products entered the national basic medicine catalog and 25 national medical insurance products. Among them, the four flavors of Zhen Layer Ice Boron Eye Drops (Zhenshi Ming Eye Drops) were included in the National Pharmacopeia and were designated as the teenager's eye drops for myopia designated by the State Education Commission (Document No. 66 of the Education Department [1992]. The company has nearly 100 million yuan. A consumer group with students as the main force. Since 2012, the company has vigorously expanded its health consumer goods business and successfully developed and launched Zhenshiming steam eye masks, eye patches, eye washes and other products.
Renhe (Group) Development Co., Ltd.
Shining brand eye protection products were launched in 2003. Shining products have always won the favor of consumers with their excellent quality and have grown into a well-known brand product in the Chinese eye drop market. The "Shining" brand adheres to the concept of "we are not only a company that conveys health, but also a positive belief in life". In addition to providing consumers with professional and high-quality eye protection products, it is more active in conveying to consumers" to realize one's own self-realization. , constantly pursue life and realize your dreams” spirit. The "shiny" brand continues to innovate and make breakthroughs in the field of Chinese entertainment marketing with the spirit of "personality, vitality and creativity". Large-scale entertainment activities across the country, including "Renhe Shining New Anchor" in 2005 and "Renhe Shining Happy Boy" in 2007, have all been successful. The "Shining" trademark was approved for registration in February 2000. At present, the "Shining" trademark has been registered in 22 countries and regions including Japan, South Korea, the United States, and Europe.
Renhe (Group) Development Co., Ltd.
Shining brand eye protection products were launched in 2003. Shining products have always won the favor of consumers with their excellent quality and have grown into a well-known brand product in the Chinese eye drop market. The "Shining" brand adheres to the concept of "we are not only a company that conveys health, but also a positive belief in life". In addition to providing consumers with professional and high-quality eye protection products, it is more active in conveying to consumers" to realize one's own self-realization. , constantly pursue life and realize your dreams” spirit. The "shiny" brand continues to innovate and make breakthroughs in the field of Chinese entertainment marketing with the spirit of "personality, vitality and creativity". Large-scale entertainment activities across the country, including "Renhe Shining New Anchor" in 2005 and "Renhe Shining Happy Boy" in 2007, have all been successful. The "Shining" trademark was approved for registration in February 2000. At present, the "Shining" trademark has been registered in 22 countries and regions including Japan, South Korea, the United States, and Europe.
Alcon (China) Ophthalmic Products Co., Ltd.
Alcon is a global leader in the field of ophthalmic health care, focusing on helping people see a brighter world. With a history of more than 75 years, Alcon is one of the world's largest ophthalmic nursing equipment companies, with complementary business advantages in surgical products and vision care. In 1945, two pharmacists, Robert Alexander and William Conner, opened a small pharmacy in Fort Worth, Texas, and combined the syllables of their last name into the pharmacy name "Alcon". Alcon has achieved its position in the ophthalmology field through innovative and breakthrough technologies, and has improved the way people treat eye diseases and improve vision. Alcon has a wealth of ophthalmic products in the industry, divided into two major business areas: ophthalmic surgery and vision care. Alcon provides a wide range of ophthalmic surgical products that can cover the entire life cycle of ophthalmic diseases, helping doctors achieve better treatment results. The product portfolio includes advanced technology intraocular lenses, comprehensive refractive cataract platform, digital vitreous retinal surgery platform and visual quality refractive integrated platform. Alcon's high-quality contact lenses and care liquid products can meet the needs of all kinds of consumers. Contact lens products include transparent daily throwing, color daily throwing and monthly throwing contact lenses. Contact lens care liquid and eye moisturizing products can bring consumers a lasting and comfortable wearing experience. In addition, the Alcon family of artificial tears products can help alleviate the increasingly severe symptoms of dry eyes.
Alcon (China) Ophthalmic Products Co., Ltd.
Alcon is a global leader in the field of ophthalmic health care, focusing on helping people see a brighter world. With a history of more than 75 years, Alcon is one of the world's largest ophthalmic nursing equipment companies, with complementary business advantages in surgical products and vision care. In 1945, two pharmacists, Robert Alexander and William Conner, opened a small pharmacy in Fort Worth, Texas, and combined the syllables of their last name into the pharmacy name "Alcon". Alcon has achieved its position in the ophthalmology field through innovative and breakthrough technologies, and has improved the way people treat eye diseases and improve vision. Alcon has a wealth of ophthalmic products in the industry, divided into two major business areas: ophthalmic surgery and vision care. Alcon provides a wide range of ophthalmic surgical products that can cover the entire life cycle of ophthalmic diseases, helping doctors achieve better treatment results. The product portfolio includes advanced technology intraocular lenses, comprehensive refractive cataract platform, digital vitreous retinal surgery platform and visual quality refractive integrated platform. Alcon's high-quality contact lenses and care liquid products can meet the needs of all kinds of consumers. Contact lens products include transparent daily throwing, color daily throwing and monthly throwing contact lenses. Contact lens care liquid and eye moisturizing products can bring consumers a lasting and comfortable wearing experience. In addition, the Alcon family of artificial tears products can help alleviate the increasingly severe symptoms of dry eyes.
Mentholatum (China) Pharmaceutical Co., Ltd.
Leton, the name born in 1899, has become synonymous with eye drops. Since the first bottle of eye drops was developed in 1909, Leton has been constantly investing in new things in the field of eye protection. In order to make eye protection safer and more convenient, in 1931, Leton designed the world's first "drip" double-mouth eye drop bottle, which was revolutionary and ended the era of separation of eye drop containers and eye droppers. In 1964, Leduan launched the classic "V·Leduan" brand eye drops, which adopted a unique cooling formula for the first time among his peers, and began to continuously lead the trend of eye protection. In 1990, Ledun came to China and introduced the Ledun Eye Drops series in 1995, which has since opened up a new concept of eye protection for Chinese consumers. Centennium Leton continues to care for every pair of eyes.
Mentholatum (China) Pharmaceutical Co., Ltd.
Leton, the name born in 1899, has become synonymous with eye drops. Since the first bottle of eye drops was developed in 1909, Leton has been constantly investing in new things in the field of eye protection. In order to make eye protection safer and more convenient, in 1931, Leton designed the world's first "drip" double-mouth eye drop bottle, which was revolutionary and ended the era of separation of eye drop containers and eye droppers. In 1964, Leduan launched the classic "V·Leduan" brand eye drops, which adopted a unique cooling formula for the first time among his peers, and began to continuously lead the trend of eye protection. In 1990, Ledun came to China and introduced the Ledun Eye Drops series in 1995, which has since opened up a new concept of eye protection for Chinese consumers. Centennium Leton continues to care for every pair of eyes.
Shangdong Lu Shang Freda Pharmaceutical Co., Ltd.
Lushang Furuida Pharmaceutical Co., Ltd. (stock code: 600223) is a pharmaceutical and cosmetics group with medicine and cosmetics as its core business, combining production, education and research, and integrating science, industry and trade. It is the creator of China's hyaluronic acid industry. The leader, whose industries are involved in raw materials, drugs, medical devices, health food, food, cosmetics, etc. The company has always adhered to innovation and development, with market demand as the core and product innovation as the leader, invested 100 million to 200 million R&D funds every year, established a R&D team of more than 360 people, and established four national-level enterprises, including the National Enterprise Technology Center, Academician Workstation, and 15 provincial platforms have established long-term and stable cooperative relations with well-known universities and research institutes such as Zhejiang University and the Shanghai Institute of Pharmaceuticals of the Chinese Academy of Sciences. They have successively undertaken more than 30 major national and provincial scientific and technological projects at the national and ministerial levels and have been authorized 270 patents. There are seven production bases in Jinan, Linyi, Jining, Yining, Xinjiang, etc., including biofermentation raw materials, plant extraction raw materials, chemical synthetic raw materials, pharmaceutical preparations, skin and fragrance care and cosmetics. Established a quality assurance system that is in line with international quality supervision concepts such as ICH, FDA, EDQM, PMDA, etc. All preparations and varieties have passed the national new version of GMP certification. With excellent product quality and customer-first service concept, they have established a medical and health field. The brand image of "Furida" has created many well-known brands such as "Runshu", "Runjie", "Shipei", "Mingren", "Yilian", and "Dr. Aier". The products are sold to North America, the EU, Japan and South Korea. , Southeast Asia and more than 70 countries and regions. In the future, Freda adheres to the corporate mission of "technology creates a healthy ecology", accelerates the reshaping of the value of "strategy, business, organization, and culture", and implements the "1234" high-quality innovation and development strategy, namely: consolidating the leading advantage of hyaluronic acid, Focus on the two main businesses, make the pharmaceutical sector special and expand the pharmaceutical sector, strengthen and optimize the cosmetic sector, promote the development of the "three modernizations", take the path of differentiated, ecological and internationalized development, implement the four major projects, and continue to promote R&D-driven, Talent-leading, brand-driven, and digital-enabled empowerment are committed to becoming an internationally renowned leading pharmaceutical and health enterprise that society trusts.
Shangdong Lu Shang Freda Pharmaceutical Co., Ltd.
Lushang Furuida Pharmaceutical Co., Ltd. (stock code: 600223) is a pharmaceutical and cosmetics group with medicine and cosmetics as its core business, combining production, education and research, and integrating science, industry and trade. It is the creator of China's hyaluronic acid industry. The leader, whose industries are involved in raw materials, drugs, medical devices, health food, food, cosmetics, etc. The company has always adhered to innovation and development, with market demand as the core and product innovation as the leader, invested 100 million to 200 million R&D funds every year, established a R&D team of more than 360 people, and established four national-level enterprises, including the National Enterprise Technology Center, Academician Workstation, and 15 provincial platforms have established long-term and stable cooperative relations with well-known universities and research institutes such as Zhejiang University and the Shanghai Institute of Pharmaceuticals of the Chinese Academy of Sciences. They have successively undertaken more than 30 major national and provincial scientific and technological projects at the national and ministerial levels and have been authorized 270 patents. There are seven production bases in Jinan, Linyi, Jining, Yining, Xinjiang, etc., including biofermentation raw materials, plant extraction raw materials, chemical synthetic raw materials, pharmaceutical preparations, skin and fragrance care and cosmetics. Established a quality assurance system that is in line with international quality supervision concepts such as ICH, FDA, EDQM, PMDA, etc. All preparations and varieties have passed the national new version of GMP certification. With excellent product quality and customer-first service concept, they have established a medical and health field. The brand image of "Furida" has created many well-known brands such as "Runshu", "Runjie", "Shipei", "Mingren", "Yilian", and "Dr. Aier". The products are sold to North America, the EU, Japan and South Korea. , Southeast Asia and more than 70 countries and regions. In the future, Freda adheres to the corporate mission of "technology creates a healthy ecology", accelerates the reshaping of the value of "strategy, business, organization, and culture", and implements the "1234" high-quality innovation and development strategy, namely: consolidating the leading advantage of hyaluronic acid, Focus on the two main businesses, make the pharmaceutical sector special and expand the pharmaceutical sector, strengthen and optimize the cosmetic sector, promote the development of the "three modernizations", take the path of differentiated, ecological and internationalized development, implement the four major projects, and continue to promote R&D-driven, Talent-leading, brand-driven, and digital-enabled empowerment are committed to becoming an internationally renowned leading pharmaceutical and health enterprise that society trusts.
Reckitt Benckiser Household Products (China) Co., Ltd.
Optrex, a well-known British eye drop brand, is an eye care brand that you have seen more in British supermarkets or pharmacies. Optrex refreshing eye drops are specially designed for eye fatigue, eye aches and other eye discomfort caused by modern lifestyles. It is suitable for long-term use of computers, driving, reading books, and other excessive eye use, wearing contact lenses, air pollution, dust, using air conditioners, etc., causing eye fatigue, eye aches and other uncomfortable symptoms. Contains pure natural plant extract essence that moisturizes and improves eye fatigue and eye pain. Safe formula, not irritating the eyes. After the drip, the symptoms of eye fatigue will be quickly relieved. Optrex eye wash is professional and effective in removing makeup residues, dry eyes and bacteria from the eyes, and pressing them on the eyes to let the liquid flow in the eyeballs, so that the dirt in the eyes can be washed out.
Reckitt Benckiser Household Products (China) Co., Ltd.
Optrex, a well-known British eye drop brand, is an eye care brand that you have seen more in British supermarkets or pharmacies. Optrex refreshing eye drops are specially designed for eye fatigue, eye aches and other eye discomfort caused by modern lifestyles. It is suitable for long-term use of computers, driving, reading books, and other excessive eye use, wearing contact lenses, air pollution, dust, using air conditioners, etc., causing eye fatigue, eye aches and other uncomfortable symptoms. Contains pure natural plant extract essence that moisturizes and improves eye fatigue and eye pain. Safe formula, not irritating the eyes. After the drip, the symptoms of eye fatigue will be quickly relieved. Optrex eye wash is professional and effective in removing makeup residues, dry eyes and bacteria from the eyes, and pressing them on the eyes to let the liquid flow in the eyeballs, so that the dirt in the eyes can be washed out.
Zhuhai United Laboratories Co., Ltd.
Federal Pharmaceutical was founded in 1990 and listed in Hong Kong in 2007. The stock code is 3933.HK, mainly engaged in the research and development, production and sales of drugs. After more than 30 years of development, Federal Pharmaceutical has formed a comprehensive pharmaceutical group with four major business segments: preparations, raw materials, biology, and animal welfare, and nine production and R&D entities. Its sales network covers the world and currently has more than 16,000 employees. Since its establishment, Federal Pharmaceuticals has been committed to providing high-quality products and services to the society and promoting high-quality development of the pharmaceutical industry. It is one of the leading comprehensive pharmaceutical companies in China. Zhuhai Federal Pharmaceutical Co., Ltd. was registered and established in 1993. The factory was completed and put into production in 1998. Currently, production bases have been established in Sanzao Town and Nanshui Town, Jinwan District, Zhuhai City, covering a total area of 450,000 square meters and employees are about 2,700. people. After more than 20 years of development, it has become a high-tech modern comprehensive pharmaceutical enterprise integrating production and R&D. The company's main products include more than 50 varieties of insulin, penicillin, cephalosporin, carat, and penem. Oral semi-synthetic penicillin workshop is currently a production workshop with a large production capacity of similar products in China, with an annual production capacity of more than 5,000 tons. The annual production capacity of the "Golden Feiyan" and "Silver Feiyan" brand products of the cephalosporin series and the carat series are about 1,000 tons. Products sold worldwide. Federal Pharmaceuticals is a company that uses genetically engineered Pichia cerevisia expression technology to produce insulin products, and is also a company that has an insulin prefilled pen assembly line in China. In 2009, the second generation of insulin human insulin (Yusling) was launched. In 2016, the third generation of insulin analog insulin glargine (Yusling) was launched. In 2021, the insulin aspart was launched, and Federal Pharmaceutical became the same. Domestic companies with second and third generation insulin production capabilities. After the project reaches full production, the production capacity will reach 3 tons of raw materials and 300 million preparations, with an annual output value of more than 10 billion yuan. Introducing intelligent manufacturing, Zhuhai Company is an enterprise that adds sterile operation robot intervention system to the sterile raw material industry. It uses robots instead of manual operation in A-level clean areas to ensure the quality of sterile drugs and reduce safety risks. The explored intelligent manufacturing has a profound impact on the quality assurance of sterile pharmaceuticals and the application of industrial intelligence. Taking a diversified development path, Federal Peptide Beauty is a company that has created a polypeptide cosmetic raw material brand for skin care. Its main effects include whitening, firming, anti-wrinkle and anti-aging. In 2017, the use of peptide raw materials into finished cosmetics began, opening a new era of federal peptide beauty skin care. In line with the international level, the quality system insists on international capacity building, and Zhuhai Company always puts quality work first. All series of products such as insulin and antibiotics have passed the domestic GMP compliance test. Amoxicillin and ampicillin raw materials have been subjected to German GMP certification inspections many times. Amoxicillin sodium, potassium clavulanate and other sterile raw materials have obtained the EU CEP certificate, and sterile raw materials such as ampicillin sodium and sulbactam sodium Together, we have successively passed the official joint GMP inspections of EDQM and Spain and other officials. In the future, Federal Pharmaceutical will continue to promote industrial upgrading and innovative development, develop more safe and effective drugs, and make greater contributions to human health.
Zhuhai United Laboratories Co., Ltd.
Federal Pharmaceutical was founded in 1990 and listed in Hong Kong in 2007. The stock code is 3933.HK, mainly engaged in the research and development, production and sales of drugs. After more than 30 years of development, Federal Pharmaceutical has formed a comprehensive pharmaceutical group with four major business segments: preparations, raw materials, biology, and animal welfare, and nine production and R&D entities. Its sales network covers the world and currently has more than 16,000 employees. Since its establishment, Federal Pharmaceuticals has been committed to providing high-quality products and services to the society and promoting high-quality development of the pharmaceutical industry. It is one of the leading comprehensive pharmaceutical companies in China. Zhuhai Federal Pharmaceutical Co., Ltd. was registered and established in 1993. The factory was completed and put into production in 1998. Currently, production bases have been established in Sanzao Town and Nanshui Town, Jinwan District, Zhuhai City, covering a total area of 450,000 square meters and employees are about 2,700. people. After more than 20 years of development, it has become a high-tech modern comprehensive pharmaceutical enterprise integrating production and R&D. The company's main products include more than 50 varieties of insulin, penicillin, cephalosporin, carat, and penem. Oral semi-synthetic penicillin workshop is currently a production workshop with a large production capacity of similar products in China, with an annual production capacity of more than 5,000 tons. The annual production capacity of the "Golden Feiyan" and "Silver Feiyan" brand products of the cephalosporin series and the carat series are about 1,000 tons. Products sold worldwide. Federal Pharmaceuticals is a company that uses genetically engineered Pichia cerevisia expression technology to produce insulin products, and is also a company that has an insulin prefilled pen assembly line in China. In 2009, the second generation of insulin human insulin (Yusling) was launched. In 2016, the third generation of insulin analog insulin glargine (Yusling) was launched. In 2021, the insulin aspart was launched, and Federal Pharmaceutical became the same. Domestic companies with second and third generation insulin production capabilities. After the project reaches full production, the production capacity will reach 3 tons of raw materials and 300 million preparations, with an annual output value of more than 10 billion yuan. Introducing intelligent manufacturing, Zhuhai Company is an enterprise that adds sterile operation robot intervention system to the sterile raw material industry. It uses robots instead of manual operation in A-level clean areas to ensure the quality of sterile drugs and reduce safety risks. The explored intelligent manufacturing has a profound impact on the quality assurance of sterile pharmaceuticals and the application of industrial intelligence. Taking a diversified development path, Federal Peptide Beauty is a company that has created a polypeptide cosmetic raw material brand for skin care. Its main effects include whitening, firming, anti-wrinkle and anti-aging. In 2017, the use of peptide raw materials into finished cosmetics began, opening a new era of federal peptide beauty skin care. In line with the international level, the quality system insists on international capacity building, and Zhuhai Company always puts quality work first. All series of products such as insulin and antibiotics have passed the domestic GMP compliance test. Amoxicillin and ampicillin raw materials have been subjected to German GMP certification inspections many times. Amoxicillin sodium, potassium clavulanate and other sterile raw materials have obtained the EU CEP certificate, and sterile raw materials such as ampicillin sodium and sulbactam sodium Together, we have successively passed the official joint GMP inspections of EDQM and Spain and other officials. In the future, Federal Pharmaceutical will continue to promote industrial upgrading and innovative development, develop more safe and effective drugs, and make greater contributions to human health.
Santen Pharmaceutical (China) Co., Ltd.
Tantian was founded in 1890 and has a history of more than 130 years. As a company focusing on ophthalmology medicine, Tantian is mainly engaged in the research, development, marketing and sales of drugs, over-the-counter products and medical devices. Its products now cover patients in more than 60 countries/regions. The word "tower" comes from "Doing the Mean", and the corporate philosophy (the participation of heaven and earth) contributes to understanding the laws of heaven and earth and all things and human health. We devote our efforts to the professional field of ophthalmology to cultivate towering wisdom and organizational capabilities, focus on patients and those who care about patients, and contribute to society. Tantian has been engaged in the research and development of new ophthalmic drugs for a long time, with a total of 29 subsidiaries around the world. In addition to Japan, it also has branches for development, research, production and sales in Europe, the United States, and Asian countries. At the same time, development and sales activities are carried out in many countries around the world. The market share of towering ophthalmic prescription drugs ranks first in Japan and South Korea. It produces about 400 million bottles of eye drops annually, and its products are sold to more than 60 countries, providing ophthalmic solutions to more than 30 million ophthalmic patients around the world each year.
Santen Pharmaceutical (China) Co., Ltd.
Tantian was founded in 1890 and has a history of more than 130 years. As a company focusing on ophthalmology medicine, Tantian is mainly engaged in the research, development, marketing and sales of drugs, over-the-counter products and medical devices. Its products now cover patients in more than 60 countries/regions. The word "tower" comes from "Doing the Mean", and the corporate philosophy (the participation of heaven and earth) contributes to understanding the laws of heaven and earth and all things and human health. We devote our efforts to the professional field of ophthalmology to cultivate towering wisdom and organizational capabilities, focus on patients and those who care about patients, and contribute to society. Tantian has been engaged in the research and development of new ophthalmic drugs for a long time, with a total of 29 subsidiaries around the world. In addition to Japan, it also has branches for development, research, production and sales in Europe, the United States, and Asian countries. At the same time, development and sales activities are carried out in many countries around the world. The market share of towering ophthalmic prescription drugs ranks first in Japan and South Korea. It produces about 400 million bottles of eye drops annually, and its products are sold to more than 60 countries, providing ophthalmic solutions to more than 30 million ophthalmic patients around the world each year.
Zhongshan Wanhan Pharmaceutical Co., Ltd.
Zhongshan Wanhan Pharmaceutical Co., Ltd. was founded in 2013 and is a high-tech enterprise integrating drug research and development, production and sales. It covers an area of 100 mu and has built a production and quality management system that meets the requirements of GMP and European and American drug quality management guidelines. It is a well-known domestically renowned anti-influenza drugs, eye drops, weight loss drugs and raw materials manufacturers. Have the ability to develop and produce raw materials. There are 4 multi-functional raw material production workshops and independent precision baking bags, thousands of reaction equipment; the storage facilities are complete and special chemical storage qualifications; oral solid preparations, eye drops, injections, and membranes that meet GMP requirements , ointment and liniment production workshop. The production capacity of oral solid preparations is 500 million doses/year, and the eye drops is 100 million doses/year; it has the ability to undertake CMO/CDMO business of related dosage forms; it has reliable drug quality control capabilities, equipped with LC-MS, HPLC, GC, HPIC , micro leakage sealing tester, fully automatic endotoxin measuring instrument and other advanced analytical and inspection instruments; have the ability to complete the development, verification and daily inspection of physical and chemical, instruments, microorganisms, endotoxins and aseptic methods.
Zhongshan Wanhan Pharmaceutical Co., Ltd.
Zhongshan Wanhan Pharmaceutical Co., Ltd. was founded in 2013 and is a high-tech enterprise integrating drug research and development, production and sales. It covers an area of 100 mu and has built a production and quality management system that meets the requirements of GMP and European and American drug quality management guidelines. It is a well-known domestically renowned anti-influenza drugs, eye drops, weight loss drugs and raw materials manufacturers. Have the ability to develop and produce raw materials. There are 4 multi-functional raw material production workshops and independent precision baking bags, thousands of reaction equipment; the storage facilities are complete and special chemical storage qualifications; oral solid preparations, eye drops, injections, and membranes that meet GMP requirements , ointment and liniment production workshop. The production capacity of oral solid preparations is 500 million doses/year, and the eye drops is 100 million doses/year; it has the ability to undertake CMO/CDMO business of related dosage forms; it has reliable drug quality control capabilities, equipped with LC-MS, HPLC, GC, HPIC , micro leakage sealing tester, fully automatic endotoxin measuring instrument and other advanced analytical and inspection instruments; have the ability to complete the development, verification and daily inspection of physical and chemical, instruments, microorganisms, endotoxins and aseptic methods.
Lushang Freda Pharmaceutical Co., Ltd.
In 2005, the American Bauschloon Company invested in Shandong Zhengda Furuida Pharmaceutical Co., Ltd. and established Shandong Bauschloon Furuida Pharmaceutical Co., Ltd. Shandong Zhengda Furuida Pharmaceutical Co., Ltd. was established in 1991. It is a Sino-foreign joint venture jointly invested by Shandong Furuida Pharmaceutical Group Co., Ltd., Thailand Zhengda Pharmaceutical Group and American Furuida International Co., Ltd., focusing on biotechnology products and biochemistry. Research, development, production and sales of drugs. Professional modern biotechnology has enabled it to reach an international level in the research and application of sodium hyaluronate series products. The company has formed the development and production capacity of ophthalmic drugs, surgical drugs, dermatology drugs and internal medicine series. The ophthalmic products "Runshu", "Runjie" and "Shipete" for osteoarthritis treatment have become outstanding domestic brands. Excellent production and testing equipment, national GMP certified purification factory, high-quality corporate employees, and meticulous and strict scientific management provide guarantees for the production of high-quality and trustworthy products, so that patients can get from safe products Get benefits. The company provides services to customers through a nationwide sales network and keeps in touch with changing market demands at any time to win the trust and respect of customers. In terms of ophthalmic drugs, the over-the-counter drug Runjie eye drop series under Bausch Lon has been recognized by the public after years of practical and time verification. It has become a well-known brand of ophthalmic drugs in China. Its products care about the eyes health of people at all stages from children to adults. .
Lushang Freda Pharmaceutical Co., Ltd.
In 2005, the American Bauschloon Company invested in Shandong Zhengda Furuida Pharmaceutical Co., Ltd. and established Shandong Bauschloon Furuida Pharmaceutical Co., Ltd. Shandong Zhengda Furuida Pharmaceutical Co., Ltd. was established in 1991. It is a Sino-foreign joint venture jointly invested by Shandong Furuida Pharmaceutical Group Co., Ltd., Thailand Zhengda Pharmaceutical Group and American Furuida International Co., Ltd., focusing on biotechnology products and biochemistry. Research, development, production and sales of drugs. Professional modern biotechnology has enabled it to reach an international level in the research and application of sodium hyaluronate series products. The company has formed the development and production capacity of ophthalmic drugs, surgical drugs, dermatology drugs and internal medicine series. The ophthalmic products "Runshu", "Runjie" and "Shipete" for osteoarthritis treatment have become outstanding domestic brands. Excellent production and testing equipment, national GMP certified purification factory, high-quality corporate employees, and meticulous and strict scientific management provide guarantees for the production of high-quality and trustworthy products, so that patients can get from safe products Get benefits. The company provides services to customers through a nationwide sales network and keeps in touch with changing market demands at any time to win the trust and respect of customers. In terms of ophthalmic drugs, the over-the-counter drug Runjie eye drop series under Bausch Lon has been recognized by the public after years of practical and time verification. It has become a well-known brand of ophthalmic drugs in China. Its products care about the eyes health of people at all stages from children to adults. .
China Otsuka Pharmaceutical Co., Ltd.
China Otsuka Pharmaceutical Co., Ltd. was jointly established by China Pharmaceutical Investment Co., Ltd. and Japan Otsuka Pharmaceutical Co., Ltd. It was approved and established in April 1981 and officially put into production on May 17, 1984. At the end of 2009, Tianjin Municipal Pharmaceutical Group Co., Ltd. has become one of the Chinese shareholders. China and Japan each hold 50% of the shares. The company has now become a comprehensive pharmaceutical manufacturer with COP brand large infusion, ampoule injection, eye drops and nutrition infusion products. It has established 29 branches across the country, covering 31 provinces, cities and regions across the country, forming It has a sales network throughout the country; and it already has two holding subsidiaries, including Guangdong Otsuka Pharmaceutical Co., Ltd. and Dalian Otsuka Pharmaceutical Co., Ltd. The company's headquarters is located in Xiqing District, Tianjin, with a factory covering an area of more than 100,000 square meters. The company has multiple advanced technology production lines, which can produce 4 major categories and 46 varieties of soft bag infusion, plastic bottle infusion and plastic ampoule injection products, as well as multiple eye drops and nutrition infusion products. Over the past 30 years, the products have been put on the market, and the quality of clinical infusion products has been stable with advanced technology and strict management. The products have been rated as national and local high-quality products many times and are welcomed by medical workers and patients.
China Otsuka Pharmaceutical Co., Ltd.
China Otsuka Pharmaceutical Co., Ltd. was jointly established by China Pharmaceutical Investment Co., Ltd. and Japan Otsuka Pharmaceutical Co., Ltd. It was approved and established in April 1981 and officially put into production on May 17, 1984. At the end of 2009, Tianjin Municipal Pharmaceutical Group Co., Ltd. has become one of the Chinese shareholders. China and Japan each hold 50% of the shares. The company has now become a comprehensive pharmaceutical manufacturer with COP brand large infusion, ampoule injection, eye drops and nutrition infusion products. It has established 29 branches across the country, covering 31 provinces, cities and regions across the country, forming It has a sales network throughout the country; and it already has two holding subsidiaries, including Guangdong Otsuka Pharmaceutical Co., Ltd. and Dalian Otsuka Pharmaceutical Co., Ltd. The company's headquarters is located in Xiqing District, Tianjin, with a factory covering an area of more than 100,000 square meters. The company has multiple advanced technology production lines, which can produce 4 major categories and 46 varieties of soft bag infusion, plastic bottle infusion and plastic ampoule injection products, as well as multiple eye drops and nutrition infusion products. Over the past 30 years, the products have been put on the market, and the quality of clinical infusion products has been stable with advanced technology and strict management. The products have been rated as national and local high-quality products many times and are welcomed by medical workers and patients.
Guangdong Hengjian Pharmaceutical Co., Ltd.
Guangdong Hengjian Pharmaceutical Co., Ltd. is a national high-tech enterprise integrating the production of drugs, medical devices and cosmetics. It currently has tablets, capsules, granules, ointments, creams, gels, tinctures, liniments, rubbers. More than 120 drug products, including pastes, solutions, eye drops, nose drops, raw materials, pharmaceutical excipients, etc., more than 120 drug varieties, medical devices, cosmetics, etc. The company currently has more than 500 employees. In order to develop the company's business in multiple directions, it also owns Guangdong Hengjian Daily Chemical Co., Ltd. and Guangdong Huaxia Youmei Biotechnology Co., Ltd. specializes in the production and sales of cosmetics. It cooperates with the PhD team of universities to focus on the development of natural herbal skin care cosmetics. The company is located in the National High-tech Development Zone of Jiangmen City. The factory covers an area of 61,000 square meters and has a construction area of 48,000 square meters. It has a clean workshop and advanced production line that is compatible with the types of drug products. It is equipped with gas chromatograph, high-performance liquid chromatograph, infrared A large number of advanced detection equipment such as spectrophotometers and atomic absorption spectrophotometers have high production efficiency and quality control level. All production workshops of the company have passed the GMP certification for the new version (2010 version). In recent years, the company's business has developed well, and its sales network covers all provinces, cities and autonomous regions across the country. Its main products include cefixime granules, cefalexin capsules, sedrosol, hydrogen peroxide solution, mercury bromine red solution, hemostatic patch (Band-Aid patch), and anti-inflammatory. Analgesic cream, etc. Topical medicine is a company's specialty product and has a large market share in the market. Over the years, the company has attached great importance to corporate technological innovation and healthy development, investing tens of millions of yuan each year in new product research and development and technological improvement, and established Guangdong Anti-Infectious Drug Engineering Technology Research Center, Guangdong Enterprise Technology Center, and universities and Other scientific research institutions jointly develop new products such as medicines and cosmetics. Hengjian people are pioneering and innovative in accordance with the belief of "creating excellent qualities and allowing people to last forever beautify and healthy", and provide the society with high-quality, safe and effective products.
Guangdong Hengjian Pharmaceutical Co., Ltd.
Guangdong Hengjian Pharmaceutical Co., Ltd. is a national high-tech enterprise integrating the production of drugs, medical devices and cosmetics. It currently has tablets, capsules, granules, ointments, creams, gels, tinctures, liniments, rubbers. More than 120 drug products, including pastes, solutions, eye drops, nose drops, raw materials, pharmaceutical excipients, etc., more than 120 drug varieties, medical devices, cosmetics, etc. The company currently has more than 500 employees. In order to develop the company's business in multiple directions, it also owns Guangdong Hengjian Daily Chemical Co., Ltd. and Guangdong Huaxia Youmei Biotechnology Co., Ltd. specializes in the production and sales of cosmetics. It cooperates with the PhD team of universities to focus on the development of natural herbal skin care cosmetics. The company is located in the National High-tech Development Zone of Jiangmen City. The factory covers an area of 61,000 square meters and has a construction area of 48,000 square meters. It has a clean workshop and advanced production line that is compatible with the types of drug products. It is equipped with gas chromatograph, high-performance liquid chromatograph, infrared A large number of advanced detection equipment such as spectrophotometers and atomic absorption spectrophotometers have high production efficiency and quality control level. All production workshops of the company have passed the GMP certification for the new version (2010 version). In recent years, the company's business has developed well, and its sales network covers all provinces, cities and autonomous regions across the country. Its main products include cefixime granules, cefalexin capsules, sedrosol, hydrogen peroxide solution, mercury bromine red solution, hemostatic patch (Band-Aid patch), and anti-inflammatory. Analgesic cream, etc. Topical medicine is a company's specialty product and has a large market share in the market. Over the years, the company has attached great importance to corporate technological innovation and healthy development, investing tens of millions of yuan each year in new product research and development and technological improvement, and established Guangdong Anti-Infectious Drug Engineering Technology Research Center, Guangdong Enterprise Technology Center, and universities and Other scientific research institutions jointly develop new products such as medicines and cosmetics. Hengjian people are pioneering and innovative in accordance with the belief of "creating excellent qualities and allowing people to last forever beautify and healthy", and provide the society with high-quality, safe and effective products.
Shenzhen Ruilin Pharmaceutical Co., Ltd.
The sodium hyaluronic acid eye drops are mainly used for dry eye diseases and relieve dry eye symptoms; the main ingredient is sodium hyaluronic acid. Its chemical name: a mucopolysaccharide composed of disaccharide units composed of D-glucuronic acid and N-acetyl-D-glucosamine. Founded in 1996, Shenzhen Ruilin is a professional sales company featuring general agent and academic promotion, with ophthalmology as its advantages, and focusing on the field of specialized medical care. Ruilin has successively joined forces with Japan HOYA, Germany Usfama Pharmaceuticals, South Korea LG, Switzerland AZDA, Japan Optoelectronics, Shantou Meiji Pharmaceuticals, Israeli Tiva, Hubei Keyi, Dandong Medical Chuang, Finland Icare, Germany Boehringer Ingelheim, and American Surgery Special equipment companies, American Anika and other companies have become partners. The current areas involved include ophthalmic drugs, consumables and devices, pain treatment, orthopedics, otolaryngology, liver disease, etc. Currently, the company has more than 200 employees, 80% of them are in the marketing department. Shenzhen Ruilin has set up 34 liaison offices across the country and established a sales network covering the country. Ruilin sales are a marketing model that focuses on self-operation and supplements with investment. The marketing department is an important department of the company's marketing, responsible for product positioning, academic data production, training, marketing activity planning and implementation, sales target formulation, etc. Currently, there are nearly 20 people. The R&D & Registration Department is responsible for the research and development of company products and the registration of external cooperative varieties. Ruilin's business department is responsible for bidding, circulation, data collection, investment promotion and other work. In recent years, Ruilin Pharmaceutical has begun to independently develop. Ruilin's early product, "Zuofu" (levofloxacin ear drops), obtained a new drug certificate and production approval document in 2009 and has been on the market for many years. Through international cooperation, one of the innovative drugs has global patents and is filed at the same time in China and the United States. It has completed the first phase of clinical practice in the United States and the second phase will begin in 2016. The project was also approved by the National 12th Five-Year Plan for Major New Drug Creation Project. "Earning can change life, giving can create life." While Ruilin Medicine is constantly developing, it has not forgotten to give back to society. In 2011, Shenzhen Ruilin, in conjunction with Shenzhen Lions Club and the Ophthalmology Branch of the Chinese Medical Association, jointly established the "Ruilin Ophthalmology Clinical Rescue (Lions) Special Fund". Ruilin Pharmaceutical has promised to donate 1 million yuan every year for five consecutive years to help patients with eye diseases who cannot be effectively treated due to poverty receive timely treatment. The project has entered its second five-year rescue cycle. As of 2021, Ruilin Pharmaceutical has donated a total of 10 million yuan and jointly with 213 volunteer hospitals to rescue 3,300 patients. We believe: what we do, what they see.
Shenzhen Ruilin Pharmaceutical Co., Ltd.
The sodium hyaluronic acid eye drops are mainly used for dry eye diseases and relieve dry eye symptoms; the main ingredient is sodium hyaluronic acid. Its chemical name: a mucopolysaccharide composed of disaccharide units composed of D-glucuronic acid and N-acetyl-D-glucosamine. Founded in 1996, Shenzhen Ruilin is a professional sales company featuring general agent and academic promotion, with ophthalmology as its advantages, and focusing on the field of specialized medical care. Ruilin has successively joined forces with Japan HOYA, Germany Usfama Pharmaceuticals, South Korea LG, Switzerland AZDA, Japan Optoelectronics, Shantou Meiji Pharmaceuticals, Israeli Tiva, Hubei Keyi, Dandong Medical Chuang, Finland Icare, Germany Boehringer Ingelheim, and American Surgery Special equipment companies, American Anika and other companies have become partners. The current areas involved include ophthalmic drugs, consumables and devices, pain treatment, orthopedics, otolaryngology, liver disease, etc. Currently, the company has more than 200 employees, 80% of them are in the marketing department. Shenzhen Ruilin has set up 34 liaison offices across the country and established a sales network covering the country. Ruilin sales are a marketing model that focuses on self-operation and supplements with investment. The marketing department is an important department of the company's marketing, responsible for product positioning, academic data production, training, marketing activity planning and implementation, sales target formulation, etc. Currently, there are nearly 20 people. The R&D & Registration Department is responsible for the research and development of company products and the registration of external cooperative varieties. Ruilin's business department is responsible for bidding, circulation, data collection, investment promotion and other work. In recent years, Ruilin Pharmaceutical has begun to independently develop. Ruilin's early product, "Zuofu" (levofloxacin ear drops), obtained a new drug certificate and production approval document in 2009 and has been on the market for many years. Through international cooperation, one of the innovative drugs has global patents and is filed at the same time in China and the United States. It has completed the first phase of clinical practice in the United States and the second phase will begin in 2016. The project was also approved by the National 12th Five-Year Plan for Major New Drug Creation Project. "Earning can change life, giving can create life." While Ruilin Medicine is constantly developing, it has not forgotten to give back to society. In 2011, Shenzhen Ruilin, in conjunction with Shenzhen Lions Club and the Ophthalmology Branch of the Chinese Medical Association, jointly established the "Ruilin Ophthalmology Clinical Rescue (Lions) Special Fund". Ruilin Pharmaceutical has promised to donate 1 million yuan every year for five consecutive years to help patients with eye diseases who cannot be effectively treated due to poverty receive timely treatment. The project has entered its second five-year rescue cycle. As of 2021, Ruilin Pharmaceutical has donated a total of 10 million yuan and jointly with 213 volunteer hospitals to rescue 3,300 patients. We believe: what we do, what they see.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Zhejiang Shapu Aisi Pharmaceutical Co., Ltd. was established in 1978. It is a comprehensive pharmaceutical enterprise specializing in drug research and development, production and operation. It was successfully listed on the A-share main board of the Shanghai Stock Exchange on July 2, 2014 ( Stock code: 603168). In October 2020, it successfully acquired Taizhou Obstetrics and Gynecology Hospital affiliated to Nantong University, officially entering the high-quality development of "pharmaceutical + medical care", and becoming a big health enterprise focusing on ophthalmology and obstetrics and gynecology. . The company has subsidiaries such as Zhejiang Shapu Aisi Pharmaceutical Sales Co., Ltd., Zhejiang Shapu Aisi Pharmacy Chain Co., Ltd., Taizhou Women and Children's Hospital Co., Ltd. Work hard to achieve strength, and strength creates excellence. Since its establishment, the company has passed the "High-tech Enterprise" certification for four consecutive times, and has been successively rated as "Key High-tech Enterprise of the National Torch Plan" and "Zhejiang Province Standard Innovation Enterprise". It has also been awarded "other sciences in China's chemical pharmaceutical industry" many times. Excellent product brand for drug use", "OTC excellent product brand for Chinese chemical pharmaceutical industry", "Social Responsibility Targeted Poverty Alleviation Award" and other honors. The company's main products, the anti-cataract, national second-class ophthalmic new drug "Shapuaisi" eye drops and the anti-glaucoma new drug "Daliang" eye drops were included in the "National Torch Plan Project". In addition, the company also has subdivided therapeutic areas such as antimicrobial drugs (cephalosporins), antimicrobial drugs (quinolones), water, electrolytes and acid-base balance drugs, including large-volume injections, oral solutions, tablets ( More than ten kinds of chemical preparations and traditional Chinese medicine preparation products, including cephalosporins), hard capsules (including cephalosporins), etc. Social responsibility, public welfare first. Shapu Aisi actively assumes social responsibility and devotes himself to public welfare undertakings. In recent years, the company has successively carried out a series of large-scale public welfare actions such as "Finishing China", "Concentric Circle·Government Consciousness", "Welcome a Century, and Performing Bailisha Pharmaceutical Charity to the Original Intention", and established the "Public Love Tongxin Charity Special Fund", etc. Give back to the society with practical actions, guide positive energy to spread, and continuously contribute to the development of China's public welfare undertakings.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Zhejiang Shapu Aisi Pharmaceutical Co., Ltd. was established in 1978. It is a comprehensive pharmaceutical enterprise specializing in drug research and development, production and operation. It was successfully listed on the A-share main board of the Shanghai Stock Exchange on July 2, 2014 ( Stock code: 603168). In October 2020, it successfully acquired Taizhou Obstetrics and Gynecology Hospital affiliated to Nantong University, officially entering the high-quality development of "pharmaceutical + medical care", and becoming a big health enterprise focusing on ophthalmology and obstetrics and gynecology. . The company has subsidiaries such as Zhejiang Shapu Aisi Pharmaceutical Sales Co., Ltd., Zhejiang Shapu Aisi Pharmacy Chain Co., Ltd., Taizhou Women and Children's Hospital Co., Ltd. Work hard to achieve strength, and strength creates excellence. Since its establishment, the company has passed the "High-tech Enterprise" certification for four consecutive times, and has been successively rated as "Key High-tech Enterprise of the National Torch Plan" and "Zhejiang Province Standard Innovation Enterprise". It has also been awarded "other sciences in China's chemical pharmaceutical industry" many times. Excellent product brand for drug use", "OTC excellent product brand for Chinese chemical pharmaceutical industry", "Social Responsibility Targeted Poverty Alleviation Award" and other honors. The company's main products, the anti-cataract, national second-class ophthalmic new drug "Shapuaisi" eye drops and the anti-glaucoma new drug "Daliang" eye drops were included in the "National Torch Plan Project". In addition, the company also has subdivided therapeutic areas such as antimicrobial drugs (cephalosporins), antimicrobial drugs (quinolones), water, electrolytes and acid-base balance drugs, including large-volume injections, oral solutions, tablets ( More than ten kinds of chemical preparations and traditional Chinese medicine preparation products, including cephalosporins), hard capsules (including cephalosporins), etc. Social responsibility, public welfare first. Shapu Aisi actively assumes social responsibility and devotes himself to public welfare undertakings. In recent years, the company has successively carried out a series of large-scale public welfare actions such as "Finishing China", "Concentric Circle·Government Consciousness", "Welcome a Century, and Performing Bailisha Pharmaceutical Charity to the Original Intention", and established the "Public Love Tongxin Charity Special Fund", etc. Give back to the society with practical actions, guide positive energy to spread, and continuously contribute to the development of China's public welfare undertakings.
Anqiao Pharmaceutical (Guangzhou) Co., Ltd.
In 1947, AGEPHA Pharma ("Ann Kwan") was born in Austria. For more than 70 years, Ann Kwan has devoted himself to exploring and innovative development, with ophthalmology as the core, and has developed into many fields such as internal medicine, dermatology, otolology, urology, etc. in 47 More than 60 products are sold in various countries and regions. Anping’s brand belief is “caring” - caring for society, actively fulfilling social responsibilities, understanding people’s needs, and helping them solve the difficulties and challenges brought by diseases, is the biggest driving force for brand development. In order to provide medical and health services to patients around the world, Angwang has launched strategic cooperation with Amazon in recent years. iGel eye drops have been listed on the hot list of Amazon in Europe and the United States. The reputation of "eye care expert" is deeply rooted in the hearts of the people. In order to enable Chinese consumers to purchase professional original imported OTC and health products more quickly and easily, in 2020, Angwang opened the Tmall International official store (AGEPHAPharma Overseas Flagship Store), which is for dry eye disease, conjunctivitis, The needs of different groups such as keratitis, glaucoma, and night blindness provide overall plans for prevention and treatment of eye health problems. In the future, Anzang will continue to bring health and happiness to society and strive to contribute to the positive changes in the world.
Anqiao Pharmaceutical (Guangzhou) Co., Ltd.
In 1947, AGEPHA Pharma ("Ann Kwan") was born in Austria. For more than 70 years, Ann Kwan has devoted himself to exploring and innovative development, with ophthalmology as the core, and has developed into many fields such as internal medicine, dermatology, otolology, urology, etc. in 47 More than 60 products are sold in various countries and regions. Anping’s brand belief is “caring” - caring for society, actively fulfilling social responsibilities, understanding people’s needs, and helping them solve the difficulties and challenges brought by diseases, is the biggest driving force for brand development. In order to provide medical and health services to patients around the world, Angwang has launched strategic cooperation with Amazon in recent years. iGel eye drops have been listed on the hot list of Amazon in Europe and the United States. The reputation of "eye care expert" is deeply rooted in the hearts of the people. In order to enable Chinese consumers to purchase professional original imported OTC and health products more quickly and easily, in 2020, Angwang opened the Tmall International official store (AGEPHAPharma Overseas Flagship Store), which is for dry eye disease, conjunctivitis, The needs of different groups such as keratitis, glaucoma, and night blindness provide overall plans for prevention and treatment of eye health problems. In the future, Anzang will continue to bring health and happiness to society and strive to contribute to the positive changes in the world.
Allergan (now part of AbbVie)
Refresh is a popular brand offering sodium hyaluronate-based eye drops to relieve dryness and maintain eye comfort.
Allergan (now part of AbbVie)
Refresh is a popular brand offering sodium hyaluronate-based eye drops to relieve dryness and maintain eye comfort.
Systane offers a range of eye drops, including sodium hyaluronate-based products, to relieve dryness, irritation, and discomfort caused by dry eye syndrome.
Alcon
Systane offers a range of eye drops, including sodium hyaluronate-based products, to relieve dryness, irritation, and discomfort caused by dry eye syndrome.
TheraTears is known for its eye care products, including supplements with lutein, to help maintain eye moisture and overall eye health.
Akorn Consumer Health
TheraTears is known for its eye care products, including supplements with lutein, to help maintain eye moisture and overall eye health.
Shenzhen Amos Food Technology Co., Ltd.
Blink Icelik is from Germany. After hundreds of taste tests, it uses pure fruit powder and mint, which has a natural fruit fragrance, a fresh and non-irritating taste. The packaging is designed by the top 10 Denmark designers. The packaging is fashionable and colorful. The unique rhinestones are the unique identity symbol of the Blink Iceliac brand. They are deeply loved and favored by young consumers. They are represented by the Chinese market in Asia. It is best-selling in South Korea, Japan, Singapore and other countries, and is available in Watsons 7-11, FamilyMart, China Resources Vanguard, OLE, Sam, Wife, and Miniso. blink Blink has introduced world-class suppliers to find high-quality raw materials, constantly innovate in product research and development, carefully integrate various unique fashion flavors, and brings consumers an extraordinary fresh and refreshing experience.
Shenzhen Amos Food Technology Co., Ltd.
Blink Icelik is from Germany. After hundreds of taste tests, it uses pure fruit powder and mint, which has a natural fruit fragrance, a fresh and non-irritating taste. The packaging is designed by the top 10 Denmark designers. The packaging is fashionable and colorful. The unique rhinestones are the unique identity symbol of the Blink Iceliac brand. They are deeply loved and favored by young consumers. They are represented by the Chinese market in Asia. It is best-selling in South Korea, Japan, Singapore and other countries, and is available in Watsons 7-11, FamilyMart, China Resources Vanguard, OLE, Sam, Wife, and Miniso. blink Blink has introduced world-class suppliers to find high-quality raw materials, constantly innovate in product research and development, carefully integrate various unique fashion flavors, and brings consumers an extraordinary fresh and refreshing experience.
Soothe provides eye drops that offer relief for dry, irritated eyes, with a formulation that mimics the natural lipid layer of tears.
Bausch + Lomb
Soothe provides eye drops that offer relief for dry, irritated eyes, with a formulation that mimics the natural lipid layer of tears.
